BioCentury
ARTICLE | Company News

Akzo Nobel NV, sanofi-aventis sales and marketing update

December 12, 2005 8:00 AM UTC

AKZ's Organon USA Inc. unit (Roseland, N.J.) received rights to promote SAN's Anzemet dolasetron to anesthesiologists. The serotonin (5-HT3) antagonist is approved to treat and prevent post-operative ...